{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:13:47Z","timestamp":1779923627409,"version":"3.53.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.jsat.2007.10.007","type":"journal-article","created":{"date-parts":[[2008,1,16]],"date-time":"2008-01-16T12:14:41Z","timestamp":1200485681000},"page":"245-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":165,"title":["Treatment of opioid-dependent pregnant women: Clinical and research issues"],"prefix":"10.1016","volume":"35","author":[{"given":"Hendree E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara G.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Stine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"O'Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia M.","family":"Arria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2007.10.007_bib1","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers","volume":"117","author":"Abdel-Latif","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jsat.2007.10.007_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2007.10.007_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130050559","article-title":"Alternate-day buprenorphine dosing is preferred to daily dosing by opiate-dependent humans","volume":"136","author":"Amass","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.10.007_bib4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0024-3205(94)00848-5","article-title":"Alternate-day dosing during buprenorphine treatment of opiate dependence","volume":"54","author":"Amass","year":"1994","journal-title":"Life Sciences"},{"key":"10.1016\/j.jsat.2007.10.007_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0376-8716(99)00074-5","article-title":"Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine\u2013naloxone tablet","volume":"58","author":"Amass","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0376-8716(00)00141-1","article-title":"Thrice-weekly supervised dosing with the combination buprenorphine\u2013naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans","volume":"61","author":"Amass","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib7","first-page":"39","author":"Auriacombe","year":"2000","journal-title":"Drugs and Addiction. Council of Europe"},{"key":"10.1016\/j.jsat.2007.10.007_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0006-3223(95)00219-7","article-title":"Vulnerability to fluoxetine-induced indifference syndrome among opiate addicts: A case report","volume":"38","author":"Bertschy","year":"1995","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2007.10.007_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00007691-199610000-00008","article-title":"Fluoxetine addition to methadone in addicts: Pharmacokinetic aspects","volume":"18","author":"Bertschy","year":"1996","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.jsat.2007.10.007_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s002130051096","article-title":"Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients","volume":"146","author":"Bickel","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jsat.2007.10.007_bib11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0002-9378(69)90117-3","article-title":"Pregnancy in narcotics addicts treated by medical withdrawal: The methadone detoxification program","volume":"105","author":"Blinick","year":"1969","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.jsat.2007.10.007_bib12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/070674370404901103","article-title":"Perinatal risks of untreated depression during pregnancy","volume":"49","author":"Bonari","year":"2004","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.10.007_bib13","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1523\/JNEUROSCI.0866-05.2005","article-title":"Endogenous opioids and attenuated hypothalamic\u2013pituitary\u2013adrenal axis responses to immune challenge in pregnant rats","volume":"25","author":"Brunton","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.jsat.2007.10.007_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/1097-4679(198511)41:6<851::AID-JCLP2270410621>3.0.CO;2-4","article-title":"Chemical dependence and clinical depression in pregnancy","volume":"41","author":"Burns","year":"1985","journal-title":"Journal of Clinical Psychology"},{"key":"10.1016\/j.jsat.2007.10.007_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1037\/0022-006X.74.5.955","article-title":"The use of contingency management and motivational\/skills-building therapy to treat young adults with marijuana dependence","volume":"74","author":"Carroll","year":"2006","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.jsat.2007.10.007_bib16","series-title":"State methadone treatment guidelines. (Treatment improvement protocol series 1)","author":"Center for Substance Abuse Treatment","year":"1993"},{"key":"10.1016\/j.jsat.2007.10.007_bib17","series-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. (Treatment improvement protocol series 40)","author":"Center for Substance Abuse Treatment","year":"2004"},{"key":"10.1016\/j.jsat.2007.10.007_bib18","series-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs. (Treatment improvement protocol series 43)","author":"Center for Substance Abuse Treatment","year":"2005"},{"key":"10.1016\/j.jsat.2007.10.007_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2007.10.007_bib20","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0376-8716(03)00058-9","article-title":"Pharmacokinetics of the combination tablet of buprenorphine and naloxone","volume":"70","author":"Chiang","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4278\/0890-1171-10.2.148","article-title":"Comparison of maternal absenteeism and infant illness rates among breast-feeding and formula-feeding women in two corporations","volume":"10","author":"Cohen","year":"1995","journal-title":"American Journal of Health Promotion"},{"key":"10.1016\/j.jsat.2007.10.007_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1017\/S1092852900009007","article-title":"Diagnosis and treatment of depression during pregnancy","volume":"9","author":"Cohen","year":"2004","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.jsat.2007.10.007_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0740-5472(98)00048-8","article-title":"Assessing the needs of substance abusing women. Psychometric data on the psychosocial history","volume":"17","author":"Comfort","year":"1999","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2007.10.007_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0002-9378(77)90652-4","article-title":"Perinatal addiction: Outcome and management","volume":"129","author":"Connaughton","year":"1977","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.jsat.2007.10.007_bib25","series-title":"Buprenorphine: Combating drug abuse with a unique opioid","first-page":"31","article-title":"Update of the general pharmacology of buprenorphine","author":"Cowan","year":"1995"},{"key":"10.1016\/j.jsat.2007.10.007_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v18n04_02","article-title":"Therapeutic use of the methadone fluvoxamine drug interaction","volume":"18","author":"DeMaria","year":"1999","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2007.10.007_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/10826089509060743","article-title":"Methadone dosing and pregnancy: Impact on program compliance","volume":"30","author":"DePetrillo","year":"1995","journal-title":"International Journal of Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2826.2005.01272.x","article-title":"Reduced activity of the noradrenergic system in the paraventricular nucleus at the end of pregnancy: Implications for stress hyporesponsiveness","volume":"17","author":"Douglas","year":"2005","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.jsat.2007.10.007_bib29","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1067\/mob.2002.127132","article-title":"Methadone trough levels in pregnancy","volume":"187","author":"Drozdick","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.jsat.2007.10.007_bib30","series-title":"Clinical guidelines for the use of buprenorphine during pregnancy","author":"Dunlop","year":"2003"},{"key":"10.1016\/j.jsat.2007.10.007_bib31","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: Implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clinical Pharmacokinetics"},{"issue":"Suppl 1","key":"10.1016\/j.jsat.2007.10.007_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000052034","article-title":"Comparison of buprenorphine and methadone maintenance in opiate addicts","volume":"4","author":"Eder","year":"1998","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2007.10.007_bib33","first-page":"489","article-title":"Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation","volume":"47","author":"Einarson","year":"2001","journal-title":"Canadian Family Physician"},{"key":"10.1016\/j.jsat.2007.10.007_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-3565(25)12294-5","article-title":"Buprenorphine's physical dependence potential: Antagonist-precipitated withdrawal in humans","volume":"276","author":"Eissenberg","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jsat.2007.10.007_bib35","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1467-842X.2002.tb00188.x","article-title":"Methadone-related deaths in Western Australia 1993\u20131999","volume":"26","author":"Ernst","year":"2002","journal-title":"Australian and New Zealand Journal of Public Health"},{"key":"10.1016\/j.jsat.2007.10.007_bib36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1901\/jaba.1996.29-387","article-title":"The accelerated intake: A method for increasing initial attendance to outpatient cocaine treatment","volume":"29","author":"Festinger","year":"1996","journal-title":"Journal of Applied Behavior Analysis"},{"key":"10.1016\/j.jsat.2007.10.007_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0306-4603(94)00052-Z","article-title":"Pretreatment dropout as a function of treatment delay and client variables","volume":"20","author":"Festinger","year":"1995","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2007.10.007_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0306-4603(01)00172-1","article-title":"From telephone to office: Intake attendance as a function of appointment delay","volume":"27","author":"Festinger","year":"2002","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2007.10.007_bib39","first-page":"331","article-title":"Perinatal substance abuse: Comments and perspectives","volume":"15","author":"Finnegan","year":"1991","journal-title":"Seminars in Perinatology"},{"issue":"Suppl 1","key":"10.1016\/j.jsat.2007.10.007_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000052040","article-title":"Buprenorphine maintenance in pregnant opiate addicts","volume":"4","author":"Fischer","year":"1998","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2007.10.007_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1360-0443.2000.95223910.x","article-title":"Treatment of opioid-dependent pregnant women with buprenorphine","volume":"95","author":"Fischer","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: A double-blind, double-dummy comparison study","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsat.2006.06.015","article-title":"Mood disorders affect drug treatment success of drug-dependent pregnant women","volume":"32","author":"Fitzsimons","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2007.10.007_bib44","first-page":"13","article-title":"Methadone and anti-HIV drugs","volume":"12","author":"Fornataro","year":"1999","journal-title":"The Body Positive"},{"key":"10.1016\/j.jsat.2007.10.007_bib45","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1097\/01.aids.0000183628.20041.f2","article-title":"Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction","volume":"19","author":"Friedland","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jsat.2007.10.007_bib46","first-page":"112","article-title":"The influence of pregnancy upon trough plasma levels of methadone and its opioid effects","volume":"132","author":"Gazaway","year":"1993","journal-title":"NIDA research monograph"},{"key":"10.1016\/j.jsat.2007.10.007_bib47","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0006-3223(99)00310-8","article-title":"Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: A preliminary trial","volume":"47","author":"George","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2007.10.007_bib48","first-page":"253","article-title":"The effectiveness of drug treatment","volume":"70","author":"Gerstein","year":"1992","journal-title":"Research Publications\u2014Association for Research in Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2007.10.007_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopsych.2006.04.043","article-title":"Buprenorphine duration of action: Mu-opioid receptor availability and pharmacokinetic and behavioral indices","volume":"61","author":"Greenwald","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jsat.2007.10.007_bib50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00213-001-0975-0","article-title":"Effects of buprenorphine sublingual tablet maintenance on opioid drug-seeking behavior by humans","volume":"160","author":"Greenwald","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jsat.2007.10.007_bib51","series-title":"Textbook of Substance Abuse Treatment","first-page":"563","article-title":"Treatment of pain in drug-addicted persons","author":"Gunderson","year":"2004"},{"key":"10.1016\/j.jsat.2007.10.007_bib52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00005053-199308000-00006","article-title":"Perinatal substance abusers. Psychological and social characteristics","volume":"181","author":"Haller","year":"1993","journal-title":"Journal of Nervous Mental Diseases"},{"key":"10.1016\/j.jsat.2007.10.007_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2005.03.022","article-title":"Contrasting predictors of readiness for substance abuse treatment in adults and adolescents: A latent variable analysis of DATOS and DATOS-A participants","volume":"80","author":"Handelsman","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib54","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0024-3205(00)00436-7","article-title":"Effect of buprenorphine on CYP3A activity in rat and human liver microsomes","volume":"66","author":"Ibrahim","year":"2000","journal-title":"Life Sciences"},{"key":"10.1016\/j.jsat.2007.10.007_bib55","first-page":"257","article-title":"Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors","volume":"26","author":"Iribarne","year":"1998","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.jsat.2007.10.007_bib56","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0024-3205(97)00160-4","article-title":"Involvement of cytochrome P4503A4 in N-dealkylation of buprenorphine in human liver microsomes","volume":"60","author":"Iribarne","year":"1997","journal-title":"Life Sciences"},{"key":"10.1016\/j.jsat.2007.10.007_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1472-8206.1998.tb00941.x","article-title":"In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine","volume":"12","author":"Iribarne","year":"1998","journal-title":"Fundamental and Clinical Pharmacology"},{"issue":"3 Pt 1","key":"10.1016\/j.jsat.2007.10.007_bib58","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ajog.2005.02.075","article-title":"Fetal response to maternal methadone administration","volume":"193","author":"Jansson","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.jsat.2007.10.007_bib59","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14767050701490327","article-title":"Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates","volume":"20","author":"Jansson","year":"2007","journal-title":"Journal of Maternal, Fetal and Neonatal Medicine"},{"key":"10.1016\/j.jsat.2007.10.007_bib130","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0376-8716(03)00062-0","article-title":"Use of buprenorphine in pregnancy: Patient management and effects on the neonate","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2004.08.027","article-title":"Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone","volume":"78","author":"Johnson","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00194-0","article-title":"Buprenorphine treatment of pregnant opioid--dependent women: Maternal and neonatal","volume":"63","author":"Johnson","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0963-7214.2006.00421.x","article-title":"Drug addiction during pregnancy: Advances in maternal treatment and understanding child outcomes","volume":"15","author":"Jones","year":"2006","journal-title":"Current Directions for Psychological Science"},{"key":"10.1016\/j.jsat.2007.10.007_bib62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/10550490600626721","article-title":"Post-cesarean pain management of patients maintained on methadone or buprenorphine","volume":"15","author":"Jones","year":"2006","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2007.10.007_bib63","unstructured":"Jones, H. E., Johnson, R. E., O'Grady, K. E., Jasinski, D. R., & Milio, L. (in press). Dosing adjustments in post-partum patients maintained on buprenorphine or methadone. Journal of Addiction Medicine."},{"key":"10.1016\/j.jsat.2007.10.007_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: Effects on the neonatal abstinence syndrome","volume":"79","author":"Jones","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib65","unstructured":"Jones, H. E., O'Grady, K. E., Schlundt, D., & Tuten, M. (Submitted a). Methadone maintenance vs. methadone taper: Maternal and neonatal outcomes."},{"key":"10.1016\/j.jsat.2007.10.007_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/10550490500419094","article-title":"Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: An open-label exploratory study","volume":"15","author":"Jones","year":"2006","journal-title":"American Journal of Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy: Effects and management","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1016\/j.jsat.2007.10.007_bib68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-3782(77)90017-2","article-title":"The narcotic-dependent mother: Fetal and neonatal consequences","volume":"1","author":"Kandall","year":"1977","journal-title":"Early Human Development"},{"key":"10.1016\/j.jsat.2007.10.007_bib69","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/appi.ajp.157.7.1164","article-title":"Lack of interaction of buprenorphine with flunitrazepam metabolism","volume":"157","author":"Kilicarslan","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2007.10.007_bib70","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0009-9120(02)00304-1","article-title":"A new series of 13 buprenorphine-related deaths","volume":"35","author":"Kintz","year":"2002","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.jsat.2007.10.007_bib71","series-title":"Buprenorphine therapy of opiate addiction","first-page":"109","article-title":"Buprenorphine-related deaths","author":"Kintz","year":"2002"},{"key":"10.1016\/j.jsat.2007.10.007_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsat.2004.03.007","article-title":"Identifying pregnant women at risk for early attrition from substance abuse treatment","volume":"27","author":"Kissin","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2007.10.007_bib73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0376-8716(90)90144-4","article-title":"Opiate antagonist challenges in buprenorphine-maintained patients","volume":"25","author":"Kosten","year":"1990","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib74","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archpsyc.1992.01820110058009","article-title":"Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine","volume":"49","author":"Kosten","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2007.10.007_bib75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0376-8716(01)00198-3","article-title":"Ketoconazole increases cocaine and opioid use in methadone maintained patients","volume":"66","author":"Kosten","year":"2002","journal-title":"Drug Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib76","first-page":"7","article-title":"Methadone disposition during the perinatal periods in humans","volume":"11","author":"Kreek","year":"1979","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1016\/j.jsat.2007.10.007_bib77","first-page":"193","article-title":"Drug interactions with methadone in humans","volume":"68","author":"Kreek","year":"1986","journal-title":"NIDA research monograph"},{"key":"10.1016\/j.jsat.2007.10.007_bib78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/00952997409011033","article-title":"Analyses of methadone and other drugs in maternal and neonatal body fluids: Use in evaluation of symptoms in a neonate of mother maintained on methadone","volume":"1","author":"Kreek","year":"1974","journal-title":"American Journal of Drug Alcohol Abuse"},{"key":"10.1016\/j.jsat.2007.10.007_bib79","first-page":"2081","article-title":"Are the new SSRIs safe for pregnant women?","volume":"44","author":"Kulin","year":"1998","journal-title":"Canadian Family Physician"},{"key":"10.1016\/j.jsat.2007.10.007_bib80","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib81","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/08897070209511497","article-title":"Training primary health care professionals to provide buprenorphine and LAAM treatment","volume":"23","author":"Lintzeris","year":"2002","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2007.10.007_bib82","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","article-title":"A meta-analysis of voucher-based reinforcement therapy for substance use disorders","volume":"101","author":"Lussier","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib83","first-page":"12","article-title":"Neonatal abstinence syndrome following abrupt cessation of breastfeeding","volume":"112","author":"Malpas","year":"1999","journal-title":"New Zealand Medical Journal"},{"key":"10.1016\/j.jsat.2007.10.007_bib84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10550490290088072","article-title":"Modified directly observed therapy (MDOT) for injection drug users with HIV disease","volume":"11","author":"McCance-Katz","year":"2002","journal-title":"American Journal on Addictions"},{"issue":"Suppl 4","key":"10.1016\/j.jsat.2007.10.007_bib85","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/508187","article-title":"Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine","volume":"43","author":"McCance-Katz","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2007.10.007_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2007.06.007","article-title":"Interaction between buprenorphine and atazanavir or atazanavir\/ritonavir","author":"McCance-Katz","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2007.10.007_bib87","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1086\/376907","article-title":"The protease inhibitor lopinavir\u2013ritonavir may produce opiate withdrawal in methadone-maintained patients","volume":"37","author":"McCance-Katz","year":"2003","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jsat.2007.10.007_bib88","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1521-0391.2001.tb00519.x","article-title":"Effect of opioid dependence pharmacotherapies on zidovudine disposition","volume":"10","author":"McCance-Katz","year":"2001","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2007.10.007_bib89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00042560-199808150-00004","article-title":"Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262)","volume":"18","author":"McCance-Katz","year":"1998","journal-title":"Journal of Acquired Immune Deficency Syndromes and Human Retrovirology"},{"key":"10.1016\/j.jsat.2007.10.007_bib90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2007.10.007_bib91","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000227919.81208.b2","article-title":"In utero antiepileptic drug exposure: Fetal death and malformations","volume":"67","author":"Meador","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jsat.2007.10.007_bib92","article-title":"Buprenorphine impairs intrapartum patient controlled epidural analgesia (PCEA) efficacy","author":"Meyer","year":"2007"},{"key":"10.1016\/j.jsat.2007.10.007_bib93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000275288.47258.e0","article-title":"Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy","volume":"110","author":"Meyer","year":"2007","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.jsat.2007.10.007_bib94","series-title":"Clinical guide to alcohol treatment. The community reinforcement approach","author":"Meyers","year":"1995"},{"key":"10.1016\/j.jsat.2007.10.007_bib95","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bcp.2004.04.011","article-title":"Methadone metabolism by human placenta","volume":"68","author":"Nanovskaya","year":"2004","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jsat.2007.10.007_bib96","first-page":"1936","article-title":"Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction","volume":"280","author":"National Institutes of Health Consensus Development Panel","year":"1998","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2007.10.007_bib97","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0740-5472(95)02015-2","article-title":"Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users","volume":"12","author":"Oliveto","year":"1995","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2007.10.007_bib98","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s001150050656","article-title":"Detoxification of poly-substance abusers with buprenorphine. Effects on affect, anxiety, and withdrawal symptoms","volume":"71","author":"Paetzold","year":"2000","journal-title":"Nervenarzt"},{"key":"10.1016\/j.jsat.2007.10.007_bib99","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1360-0443.1988.tb03981.x","article-title":"Assessment of opioid dependence with naloxone","volume":"83","author":"Peachey","year":"1988","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1360-0443.2000.95710698.x","article-title":"A comparison of four buprenorphine dosing regimens using open-dosing procedures: Is twice-weekly dosing possible?","volume":"95","author":"Petry","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib101","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1360-0443.2001.9668234.x","article-title":"Examining the limits of the buprenorphine interdosing interval: Daily, every-third-day and every-fifth-day dosing regimens","volume":"96","author":"Petry","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)21130-2","article-title":"Changes in methadone pharmacokinetics during pregnancy","volume":"234","author":"Pond","year":"1985","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jsat.2007.10.007_bib103","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jsgi.2005.11.001","article-title":"Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns","volume":"13","author":"Ramirez-Cacho","year":"2006","journal-title":"Journal for the Society of Gynecological Investigation"},{"key":"10.1016\/j.jsat.2007.10.007_bib104","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archpsyc.59.9.817","article-title":"A comparison of contingency management and cognitive\u2013behavioral approaches during methadone maintenance treatment for cocaine dependence","volume":"59","author":"Rawson","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2007.10.007_bib105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.apnu.2005.07.010","article-title":"A comparative study of postpartum depression in abused and nonabused women","volume":"19","author":"Records","year":"2005","journal-title":"Archives of Psychiatric Nursing"},{"key":"10.1016\/j.jsat.2007.10.007_bib106","first-page":"466","article-title":"Depression in pregnant drug-dependent women","volume":"41","author":"Regan","year":"1982","journal-title":"NIDA research monograph"},{"key":"10.1016\/j.jsat.2007.10.007_bib107","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0002-9378(73)90953-8","article-title":"Narcotic withdrawal in pregnancy: Stillbirth incidence with a case report","volume":"116","author":"Rementeria","year":"1973","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.jsat.2007.10.007_bib108","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1046\/j.1360-0443.1998.93913859.x","article-title":"Six deaths linked to concomitant use of buprenorphine and benzodiazepines","volume":"93","author":"Reynaud","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib109","first-page":"1381","article-title":"Drug interactions with methadone","volume":"28","author":"Schlatter","year":"1999","journal-title":"Presse Medicine"},{"key":"10.1016\/j.jsat.2007.10.007_bib110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0447.1992.tb03224.x","article-title":"Cases of buprenorphine abuse in India","volume":"86","author":"Singh","year":"1992","journal-title":"Acta Psychiatry Scandinavia"},{"key":"10.1016\/j.jsat.2007.10.007_bib111","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v25n03_02","article-title":"Methadone induction doses: Are our current practices safe?","volume":"25","author":"Srivastava","year":"2006","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2007.10.007_bib112","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/00952999009001573","article-title":"\u201cHello, may we help you?\u201d A study of attrition prevention at the time of the first phone contact with substance-abusing clients","volume":"16","author":"Stark","year":"1990","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2007.10.007_bib113","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4603(98)00082-3","article-title":"A comparison of three \u201cinterventions\u201d on pretreatment dropout rates in an outpatient substance abuse clinic","volume":"24","author":"Stasiewicz","year":"1999","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2007.10.007_bib114","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00126334-200308150-00016","article-title":"Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir\/ritonavir","volume":"33","author":"Stevens","year":"2003","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"key":"10.1016\/j.jsat.2007.10.007_bib115","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-3565(25)39357-2","article-title":"Precipitated withdrawal by pentazocine in methadone-maintained volunteers","volume":"267","author":"Strain","year":"1993","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jsat.2007.10.007_bib116","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/j.1552-4604.1980.tb02543.x","article-title":"Methadone\u2013disulfiram interaction during methadone maintenance","volume":"20","author":"Tong","year":"1980","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.jsat.2007.10.007_bib117","series-title":"HHS blueprint for action on breastfeeding","author":"U.S. Department of Health and Human Services","year":"2000"},{"key":"10.1016\/j.jsat.2007.10.007_bib118","series-title":"Healthy people 2010. Understanding and improving health. Chapter 16","author":"U.S. Department of Health and Human Services","year":"2000"},{"key":"10.1016\/j.jsat.2007.10.007_bib119","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0091-2182(88)90246-7","article-title":"The relationship between infant feeding method and maternal role adjustment","volume":"33","author":"Virden","year":"1988","journal-title":"Journal of Nurse-Midwifery"},{"key":"10.1016\/j.jsat.2007.10.007_bib120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2007.10.007_bib121","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","article-title":"Mechanisms of fatal opioid overdose","volume":"94","author":"White","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib122","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0378-3782(90)90114-X","article-title":"Short-term effects of early suckling and touch of the nipple on maternal behaviour","volume":"21","author":"Widstrom","year":"1990","journal-title":"Early Human Development"},{"key":"10.1016\/j.jsat.2007.10.007_bib123","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0022-3476(81)80830-X","article-title":"Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: Health, developmental, and social implications","volume":"98","author":"Wilson","year":"1981","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.jsat.2007.10.007_bib124","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10826089109053183","article-title":"A comparison of the effects of single- and split-dose methadone administration on the fetus: Ultrasound evaluation","volume":"26","author":"Wittmann","year":"1991","journal-title":"International Journal of Addiction"},{"key":"10.1016\/j.jsat.2007.10.007_bib125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00002508-200305000-00002","article-title":"Treatment of pain in pregnancy","volume":"19","author":"Wunsch","year":"2003","journal-title":"Clinical Journal of Pain"},{"key":"10.1016\/j.jsat.2007.10.007_bib126","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bcp.2006.08.019","article-title":"The effect of opiates on the activity of human placental aromatase\/CYP19","volume":"73","author":"Zharikova","year":"2007","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jsat.2007.10.007_bib127","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bcp.2005.12.035","article-title":"The effect of methadone and buprenorphine on human placental aromatase","volume":"71","author":"Zharikova","year":"2006","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.jsat.2007.10.007_bib128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9378(75)90613-4","article-title":"Fetal stress from methadone withdrawal","volume":"122","author":"Zuspan","year":"1975","journal-title":"American Journal of Obstetrics and Gynecology"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547207003285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547207003285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:32:14Z","timestamp":1760038334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547207003285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0740547207003285"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2007.10.007","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of opioid-dependent pregnant women: Clinical and research issues","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2007.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}